Clinics Explore IVF Lab Automation for Future Use

A new partnership aims to test whether robotics can increase precision and consistency for patients undergoing IVF treatment.

Updated on Oct. 27, 2026 in Pregnancy

Isometric editorial illustration of a robotic arm and laboratory pipette, symbolizing precision in medical technology.
ART Fertility Clinics and Conceivable Life Sciences have partnered to pilot robotic automation and AI-driven platforms in IVF laboratory procedures. AI Illustration. Upload story photo >

Live Poll

Do you trust robotics and AI to improve the quality of delicate medical procedures?

ART Fertility Clinics has signed a memorandum of understanding with the medical technology firm Conceivable Life Sciences to explore automating in vitro fertilization (IVF) laboratory processes. The partnership will evaluate the integration of the AURA platform, which uses robotics and artificial intelligence, at the IVI Institute.

Why it matters

As IVF demand continues to grow globally, labs are exploring how automation could potentially increase consistency and precision in handling delicate reproductive procedures. This collaboration marks an initial stage to determine if such technologies can be reliably integrated into existing clinical workflows.

This collaborative agreement involves a cohort of 500 medical professionals, embryologists, and researchers tasked with evaluating laboratory feasibility. The partnership intends to move through validation and regulatory stages, though the final efficacy of the system remains to be established.

The players

ART Fertility Clinics

A fertility care network and member of the IVI Institute that provides reproductive services and IVF treatments.

Conceivable Life Sciences

A New York-based medical technology company focused on developing robotics and AI for the fertility sector.

The details

The AURA platform utilizes a combination of physical artificial intelligence, advanced imaging, and robotics to manage laboratory workflows during the IVF process. The project focuses on site-specific feasibility studies and training programs to ensure clinical and laboratory teams can manage the new technology. Success depends on whether these automated systems can replicate or improve upon the precision currently achieved by manual laboratory techniques.

Timeline

  1. The memorandum of understanding was officially signed on October 27, 2026.

Health Landscape

This partnership represents a move toward the industrialization of IVF labs, which have historically relied on manual, highly technical oversight by embryologists. It follows a broader trend of integrating artificial intelligence and robotics into medical procedures to reduce variability in clinical outcomes.

This development is in the preliminary assessment stage and does not change your current IVF treatment options or care plan. If you are undergoing fertility treatments, it remains most effective to discuss your specific laboratory's quality protocols and success rates directly with your reproductive endocrinologist.

The takeaway

While automation in IVF is an area of active development, it is currently in early, study-based stages rather than standard practice. Patients interested in how lab technology affects success rates should speak with their fertility specialists about the clinic's current lab standards and quality control measures.

Further reading

Learn more about the latest innovations in fertility care by visiting our Pregnancy section.

Source note: This article includes information reported by Zawya.

Live Poll

Do you trust robotics and AI to improve the quality of delicate medical procedures?